Furthermore, when gender, smoking status and BCLC stage were included in the final model, the TEAD3 rs2076173 still remained as an independent protective factor for HCC survival (HR = 0.69, 95%CI = 0.54-0.89, P = 0.005). Here, TEAD3 is linked to hepatocellular carcinoma.